Population pharmacokinetic characterization of BAY 81-8973, a full-length recombinant factor VIII

Therapeutic area :

Garmann D., McLeay S., Shah A., Vis P., Maas Enriquez M., Ploeger, B.A.  Population pharmacokinetic characterization of BAY 81-8973, a full-length recombinant factor VIII: lessons learned ‒ importance of including samples with factor VIII levels below the quantitation limit. Haemophilia: 528–537, 2017. [Link to publication]